Natarajan Ranganathan
Kibow Biotech Inc. USA
Title: The concept and potential of enteric dialysis, the gut – Kidney connection
Biography
Biography: Natarajan Ranganathan
Abstract
The primary goal of this talk is to update recent scientific progress, understanding, knowledge gained and also several clinical advances made since the very first review that was published in the year 2012 (Title: Probiotics, Prebiotics and Synbiotics: Gut and Beyond in Gastroenterology Research and Practice). The use of probiotics and prebiotics is generally well recognized towards digestive, gut and immune health. However, Kibow Biotech is a R&D Biotech company involved in novel and niche application of probiotics and prebiotics as a dietary supplement in stabilization of Gut Microbiome towards Chronic Kidney Disease (CKD). Since our first review article, several other reviews have been published. These independent reviews in various scientific journals reflect various topics such as gut Microbiome, its dysbiosis, impact of the altered intestinal characteristics including small bowel bacterial overgrowth, newer uremic toxins, adsorbent drugs and several observational small scale clinical studies from us and a host of others. This talk mainly connects various aspects of scientific understanding with greater emphasis on the health economics and potentials of probiotics and prebiotics towards CKD applications both in developed and developing countries. Thus, the speaker has undertaken to revisit, review and offer his independent views in connecting the failing kidney function by the bowel. This original concept is now being more scientifically researched, commercially validated and realized as “Gut and Kidney connection”.